» Articles » PMID: 11734856

Inhibitory PAS Domain Protein is a Negative Regulator of Hypoxia-inducible Gene Expression

Overview
Journal Nature
Specialty Science
Date 2001 Dec 6
PMID 11734856
Citations 217
Authors
Affiliations
Soon will be listed here.
Abstract

Alteration of gene expression is a crucial component of adaptive responses to hypoxia. These responses are mediated by hypoxia-inducible transcription factors (HIFs). Here we describe an inhibitory PAS (Per/Arnt/Sim) domain protein, IPAS, which is a basic helix-loop-helix (bHLH)/PAS protein structurally related to HIFs. IPAS contains no endogenous transactivation function but demonstrates dominant negative regulation of HIF-mediated control of gene expression. Ectopic expression of IPAS in hepatoma cells selectively impairs induction of genes involved in adaptation to a hypoxic environment, notably the vascular endothelial growth factor (VEGF) gene, and results in retarded tumour growth and tumour vascular density in vivo. In mice, IPAS was predominantly expressed in Purkinje cells of the cerebellum and in corneal epithelium of the eye. Expression of IPAS in the cornea correlates with low levels of expression of the VEGF gene under hypoxic conditions. Application of an IPAS antisense oligonucleotide to the mouse cornea induced angiogenesis under normal oxygen conditions, and demonstrated hypoxia-dependent induction of VEGF gene expression in hypoxic corneal cells. These results indicate a previously unknown mechanism for negative regulation of angiogenesis and maintenance of an avascular phenotype.

Citing Articles

Critical roles of miR-21 in promotions angiogenesis: friend or foe?.

Saadh M, Jasim N, Ahmed M, Ballal S, Kumar A, Atteri S Clin Exp Med. 2025; 25(1):66.

PMID: 39998742 PMC: 11861128. DOI: 10.1007/s10238-025-01600-7.


Hypermethylation of Hif3a and Ifltd1 is associated with atrial remodeling in pressure-overload murine model.

Abe K, Sasano T, Soejima Y, Fukayama H, Maeda S, Furukawa T Sci Rep. 2025; 15(1):2699.

PMID: 39837857 PMC: 11751168. DOI: 10.1038/s41598-025-85382-8.


Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer.

Zhang J, Yao M, Xia S, Zeng F, Liu Q Cell Mol Biol Lett. 2025; 30(1):2.

PMID: 39757165 PMC: 11702238. DOI: 10.1186/s11658-024-00682-7.


A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway.

Pauzaite T, Nathan J Biochem Soc Trans. 2024; 52(6):2253-2265.

PMID: 39584532 PMC: 11668284. DOI: 10.1042/BST20230861.


Total loss of gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity.

Abu-Remaileh M, Persky N, Lee Y, Root D, Kaelin Jr W Proc Natl Acad Sci U S A. 2024; 121(40):e2410356121.

PMID: 39320914 PMC: 11459182. DOI: 10.1073/pnas.2410356121.